NCT00959803View on ClinicalTrials.gov

Study Of Single Ascending And Multiple Doses Of PF-04447943 In Japanese Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Healthy
Interventions
DRUG

PF-04447943

3 mg solution, oral single dose.

DRUG

PF-04447943

10 mg solution, oral single dose.

DRUG

PF-04447943

25 mg solution, oral single dose.

DRUG

Placebo

Solution, oral single dose.

DRUG

PF-04447943

25 mg solution, oral twice daily for 7 days.

DRUG

Placebo

Solution, oral twice daily for 7 days.

Trial Locations (1)

91206

Pfizer Investigational Site, Glendale

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00959803 - Study Of Single Ascending And Multiple Doses Of PF-04447943 In Japanese Subjects. | Biotech Hunter | Biotech Hunter